semaglutide aetna TrimRX aetna cover tirzepatide Does Aetna
Description
The FDA label states that providers should consider discontinuing treatment if patients do not achieve at least 5% weight loss after 12 weeks at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit
The Wegovy savings program can further reduce costs for commercially insured patients
It is important to note that orlistat can reduce levothyroxine absorption, and the BNF recommends separating administration by at least 4 hours and monitoring thyroid function
: Catalent
